Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An International Multicenter Randomized Double-blind Placebo-controlled Clinical Study of the Efficacy and Safety of Subcutaneous BCD-085 in Patients With Psoriatic Arthritis

NCT03598751 is registered in ClinicalTrials.gov with Biocad as lead sponsor.

NCT NCT03598751
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03598751 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An International Multicenter Randomized Double-blind Placebo-controlled Clinical Study of the Efficacy and Safety of Subcutaneous BCD-085 in Patients With Psoriatic Arthritis
Lead sponsor
Biocad
Phase
Phase 3
Overall status
Completed
Start date
July 25, 2018
Completion date
August 31, 2022
Enrollment
194 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

psoriatic arthritis